JP7257399B2 - 多嚢胞性卵巣症候群に罹患している女性患者における胚着床率を高める方法 - Google Patents

多嚢胞性卵巣症候群に罹患している女性患者における胚着床率を高める方法 Download PDF

Info

Publication number
JP7257399B2
JP7257399B2 JP2020528323A JP2020528323A JP7257399B2 JP 7257399 B2 JP7257399 B2 JP 7257399B2 JP 2020528323 A JP2020528323 A JP 2020528323A JP 2020528323 A JP2020528323 A JP 2020528323A JP 7257399 B2 JP7257399 B2 JP 7257399B2
Authority
JP
Japan
Prior art keywords
inositol
myo
chiro
composition
weight ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020528323A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021504360A5 (https=
JP2021504360A (ja
Inventor
マルティン、モニカ オリバレス
ホヤ、フリスト フォノリャ
メディナ、マリア パス ディアス－ロペロ
ララメンディ、ホセ ルイス ロペス
ラドロン デ ゲバラ、ニコラス メンドーサ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosearch SA
Original Assignee
Biosearch SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch SA filed Critical Biosearch SA
Publication of JP2021504360A publication Critical patent/JP2021504360A/ja
Publication of JP2021504360A5 publication Critical patent/JP2021504360A5/ja
Application granted granted Critical
Publication of JP7257399B2 publication Critical patent/JP7257399B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2020528323A 2017-11-23 2018-04-19 多嚢胞性卵巣症候群に罹患している女性患者における胚着床率を高める方法 Active JP7257399B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17382791 2017-11-23
EP17382791.6 2017-11-23
PCT/EP2018/060077 WO2019101368A1 (en) 2017-11-23 2018-04-19 Method for increasing embryo implantation rate in a female subject suffering polycystic ovary syndrome

Publications (3)

Publication Number Publication Date
JP2021504360A JP2021504360A (ja) 2021-02-15
JP2021504360A5 JP2021504360A5 (https=) 2021-05-27
JP7257399B2 true JP7257399B2 (ja) 2023-04-13

Family

ID=60569854

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020528323A Active JP7257399B2 (ja) 2017-11-23 2018-04-19 多嚢胞性卵巣症候群に罹患している女性患者における胚着床率を高める方法

Country Status (12)

Country Link
US (1) US11484540B2 (https=)
EP (1) EP3713552A1 (https=)
JP (1) JP7257399B2 (https=)
CN (1) CN111655245B (https=)
AU (1) AU2018373174B2 (https=)
BR (1) BR112020010343A2 (https=)
CA (1) CA3083301C (https=)
MA (1) MA50784A (https=)
MX (1) MX2020005223A (https=)
NZ (1) NZ765637A (https=)
TW (1) TWI842684B (https=)
WO (1) WO2019101368A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2749783C1 (ru) * 2020-12-11 2021-06-16 Федеральное государственное автономное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) Способ лечения синдрома поликистозных яичников, ассоциированного с метаболическим синдромом
CN114159402A (zh) * 2021-12-21 2022-03-11 湖州展望天明药业有限公司 一种不透明植物胶囊及其制备方法
EP4620480A1 (en) 2022-11-16 2025-09-24 Kansai Medical University Educational Corporation Implantation facilitator, and screening system therefor
CN117017929B (zh) * 2023-09-11 2024-11-08 山东奥克斯畜牧种业有限公司 一种用于提高采卵效果的组合物及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006213684A (ja) 2005-02-07 2006-08-17 Hokko Chem Ind Co Ltd インスリン抵抗性改善に用いられる組成物及び健康用食品
WO2013076121A1 (en) 2011-11-22 2013-05-30 Lo.Li. Pharma S.R.L. Pharmaceutical composition comprising myo-inositol and d-chiro-inositol
WO2017179012A1 (en) 2016-04-13 2017-10-19 S&R Farmaceutici S.P.A. Nutraceutical or pharmaceutical composition for use in the treatment of polycystic ovary syndrome or of diseases or disorders related thereto

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2047686C (en) 1989-03-08 2000-09-05 Joseph Larner Dietary supplement for insulin-resistant diabetics
US5563059A (en) 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5906979A (en) * 1998-01-27 1999-05-25 Insmed Pharmaceuticals, Inc. Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility
US7105489B2 (en) * 2002-01-22 2006-09-12 Amylin Pharmaceuticals, Inc. Methods and compositions for treating polycystic ovary syndrome
ITRM20070341A1 (it) * 2007-06-20 2008-12-21 Lo Li Pharma Srl Formulazione integrativa inofolic finalizzata al controllo dell'induzione dell'ovulazione in programmi di procreazione medicalmente assistita
EP2596132A4 (en) 2010-07-23 2013-12-18 Harvard College METHOD FOR DETECTING SIGNS FOR ILLNESS OR SUFFERING IN BODY FLUIDS
ITMI20110445A1 (it) * 2011-03-22 2012-09-23 Lo Li Pharma Srl Formulazione farmaceutica comprendente inositolo.
ITRM20130655A1 (it) * 2013-11-26 2015-05-27 Dicofarm Spa Prodotto a base di una associazione di glucomannano ed inositolo
US9259410B2 (en) 2014-04-08 2016-02-16 Oculus Innovative Sciences, Inc. Methods of treating polycystic ovarian syndrome using chlorogenic acid and inositol
IN2014MU01312A (https=) 2014-04-09 2015-10-16 Olive Healthcare
ITUA20163025A1 (it) * 2016-04-29 2017-10-29 Sochim Int S P A Composizione per il trattamento della sindrome dell’ovaio policistico

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006213684A (ja) 2005-02-07 2006-08-17 Hokko Chem Ind Co Ltd インスリン抵抗性改善に用いられる組成物及び健康用食品
WO2013076121A1 (en) 2011-11-22 2013-05-30 Lo.Li. Pharma S.R.L. Pharmaceutical composition comprising myo-inositol and d-chiro-inositol
WO2017179012A1 (en) 2016-04-13 2017-10-19 S&R Farmaceutici S.P.A. Nutraceutical or pharmaceutical composition for use in the treatment of polycystic ovary syndrome or of diseases or disorders related thereto

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
European Review for Medical and Pharmacological Sciences，2012年，Vol.16，p.575-581
Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome'，NCT03201601, [online]，2017年06月28日，[令和4年1月28日検索],インターネット<URL:https://clinicaltrials.gov/ct2/show/NCT03201601>
Expert Rev. clin. Phamacol.，2014年，vol.7, No.5，p.623-631
International Journal of Endocrinology，2016年，Volume 2016，Article ID 3204083

Also Published As

Publication number Publication date
MX2020005223A (es) 2020-10-19
EP3713552A1 (en) 2020-09-30
MA50784A (fr) 2020-09-30
BR112020010343A2 (pt) 2020-11-10
NZ765637A (en) 2025-11-28
TWI842684B (zh) 2024-05-21
CN111655245A (zh) 2020-09-11
CA3083301A1 (en) 2019-05-31
US11484540B2 (en) 2022-11-01
JP2021504360A (ja) 2021-02-15
RU2020120655A3 (https=) 2021-12-23
TW201924692A (zh) 2019-07-01
AU2018373174A1 (en) 2020-07-09
US20200330495A1 (en) 2020-10-22
CA3083301C (en) 2024-05-21
WO2019101368A1 (en) 2019-05-31
CN111655245B (zh) 2023-08-08
RU2020120655A (ru) 2021-12-23
AU2018373174B2 (en) 2024-07-25

Similar Documents

Publication Publication Date Title
Lockwood et al. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study
AU2009100215B4 (en) Methods and compositions for improving pregnancy outcome
AU2014359649B2 (en) Composition useful for promoting female fertility
JP7257399B2 (ja) 多嚢胞性卵巣症候群に罹患している女性患者における胚着床率を高める方法
Hossein-Rashidi et al. Effects of Vitex agnus-castus extract on the secretory function of pituitary-gonadal axis and pregnancy rate in patients with premature ovarian aging (POA)
CN118104819A (zh) 一种用于卵巢保健的组合物及其制备方法和应用
RU2790696C2 (ru) Способ повышения частоты имплантации эмбриона у субъекта женского пола, страдающего синдромом поликистозных яичников
RU2846245C2 (ru) Применение алкалоидов, содержащихся в веточках шелковицы, для получения лекарственного средства для лечения синдрома поликистозных яичников
HUE034809T2 (en) Composition for controlling and improving female and male gametogenesis
US11058737B2 (en) Use of Euycoma longifolia extract in alleviating symptoms and/or conditions associated with hormonal imbalance in females
KR20210005676A (ko) 여성 성기능 장애를 치료하기 위한 조성물
RU2282439C2 (ru) Фармацевтическая композиция на основе веществ, влияющих на энергетический обмен, и способ профилактики фетоплацентарной недостаточности у беременных группы высокого риска
CN109331022B (zh) 提高女性卵巢功能改善女性皮肤的组合物和制备工艺
Sharma et al. A Comprehensive Review of Management of Patients with Infertility having Polycystic Ovarian Syndrome
CN120731080A (zh) 用于治疗多囊卵巢综合征的组合物
Date Injectable Contraceptives
NZ719680B2 (en) Composition useful for promoting female fertility
HK1225295A1 (en) Composition useful for promoting female fertility

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210417

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210417

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220201

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220420

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220701

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20221025

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230217

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20230217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230217

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230309

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20230314

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230328

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230403

R150 Certificate of patent or registration of utility model

Ref document number: 7257399

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150